Psychedelic Medicine
Association
The Psychedelic Medicine Association (PMA) is dedicated to advancing the field of psychedelic medicine through clinician education. We bring medical practitioners up to speed on the latest in cutting-edge psychedelic research through comprehensive education and resources. The PMA is incorporated as a Public Benefit Corporation, and funded solely through membership dues.
Complementing this mission, we have formed a non-profit corporation that focuses on developing and implementing clinical practice guidelines and accreditation standards for psychedelic therapist training programs.
Educating, empowering, and enabling medical professionals around psychedelic medicine in ways which are as complete and unbiased as possible;
Raising awareness and advocacy in support of uptake of psychedelic medicines by insurers, public health systems and governments;
Accelerating and enhancing healthcare delivery, improving the quality of and access to patient focused solutions, especially those with the greatest access challenges;
Providing meaningful experiences to members for personal and professional development, and fostering links with other organisations;
Building a digital ecosystem to create collaboration and debate amongst medical professionals and to enable training, events, alliances and partnerships;
Catalyze novel treatments and approaches for the benefit of patients through interaction between the medical, scientific, corporate and government communities;
Discouraging exploitation, expropriation or other harmful activities, while encouraging ethical, sustainable practises. In alignment with the ethics outlined in the North Star Pledge.
The PMA endeavour to achieve best in the sector for their diversity & inclusion practices. Committed to featuring diverse voices from across the race, gender, sexual identity and ability spectrums. In addition, support those who have been and continue to be marginalized.
We at the Psychedelic Medicine Association are dedicated to being transparent with our funding. We have received no financial contributions from any of our advisors. We have not given any special preference to any organizations.
All corporations and organizations pay the same rates to be in our organization, which are based on the size of the corporation or organization. The association key funding source is member dues.
No suitably qualified member who wishes to participate in the organization will be turned away. We are committed to providing equitable access for all healthcare providers as well as for organizations doing quality work in improving access to these medicines and access to training in these therapies.
Become a member of The Psychedelic Medicine Association to gain access to a variety of educational and informational tools to help you feel confident to discuss psychedelic medicines with your patients. As a member, you’ll also be connected with like-minded health professionals and the organizations shaping the psychedelic industry.
Managing Medical Risk In Patients Seeking Psilocybin Therapy
We are excited to offer a CME/CE accredited course to provide healthcare professionals with the tools they need to safely, effectively, and comfortably assess and discuss the relevant medical risks with their patients.
In this course, you will:
